Columbia/HCA: Why Size Matters
Historically, group purchasing organizations made a choice between smaller constituents that could deliver high compliance and larger groups that made up in volume what they lacked in discipline. Then came Columbia, proving that bigger is better, through its ability to marry a large base of hospitals with committed compliance.
You may also be interested in...
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.
Pacific Biosciences of California and Aziyo Biologics both acquire new finance chiefs; Illumina hires a new chief marketing officer; WishBone Medical president moves over to take helm at Electromedical Products International; and more.